SOPHiA Genetics (SOPH) News and press releases

Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session

20 Mar 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

12 Health Care Stocks Moving In Monday's Intraday Session

20 Mar 23

Movers

12 Health Care Stocks Moving In Tuesday's After-Market Session

14 Mar 23

Movers

Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $11

8 Mar 23

News, Price Target, Analyst Ratings

Morgan Stanley analyst Tejas Savant maintains Sophia Genetics (NASDAQ:SOPH) with a Overweight and lowers the price target from $12 to $11.

Sophia Genetics Expects FY23 Revenue Growth To Be At Or Above 30%

7 Mar 23

News, Guidance, Health Care, General

Full year constant currency revenue growth excluding COVID-19-related revenue to be between 30% and 35%; and 2023 operating losses to be below 2022 levels.

Sophia Genetics Q4 Adjusted EPS $(0.17) Beats $(0.36) Estimate, Sales $13.38M Beat $12.91M Estimate

7 Mar 23

Earnings, News

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.36) by 52.78 percent. This is a 39.29 percent increase over losses of $(0.28) per share from

Earnings Scheduled For March 7, 2023

7 Mar 23

Earnings

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for its fourth quarter. • Xtant Medical Holdings (AMEX:XTNT) is expected to report earnings for its fourth quarter.

SOPHiA GENETICS And QIAGEN Forge Partnership To Combine Strengths In Next-generation Sequencing

1 Mar 23

News

SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE:QGEN) that will pair QIAseq reagent technology with the SOPHiA

Synergy Laboratories Taps SOPHiA GENETICS TechnologyFor New Cancer Profiling Solution; No Financial Terms Disclosed

28 Feb 23

News, Contracts

The New Solution uses SOPHiA DDM™ and aims to Benefit Cancer Research, Clinical Studies and Patient Care SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced that

SOPHiA GENETICS Expanded Partnership with AstraZeneca To include Multimodal Approaches For Cancer Drug Development

13 Feb 23

News, Penny Stocks

SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a leading cloud-native global data-sharing network and health analytics platform, is partnering with AstraZeneca (LSE/STO/Nasdaq: AZN) to apply their multimodal technology and expertise to the biopharmaceutical company's oncology portfolio.

SOPHiA GENETICS And Leading U.S. Cancer Center Collaborate To Combine Cancer Analysis Technology For Liquid Biopsies

10 Jan 23

Biotech, News, General

SOPHiA GENETICS™ (NASDAQ:SOPH), a cloud-native software company in the healthcare space, has entered an agreement with Memorial Sloan Kettering Cancer Center (MSK) to offer clinicians and researchers new

BTIG Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $6

3 Jan 23

News, Price Target, Initiation, Analyst Ratings

BTIG analyst Mark Massaro initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and announces Price Target of $6.

SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

14 Mar 23

Press Releases

Collaboration provides a solution for a more in-depth analysis of cancer biomarkers SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is

SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

7 Mar 23

Press Releases

Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate SOPHiA GENETICS SA (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth

SOPHiA GENETICS Named to Fast Company's Annual List of the World's Most Innovative Companies for 2023

3 Mar 23

Press Releases

Pioneer in decentralized digital health data analytics joins the ranks of OpenAI, Disney, Tiffany & Co., and more SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, has been

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023

23 Feb 23

Press Releases

SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open

SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies

10 Jan 23

Press Releases

SOPHiA GENETICS™ (NASDAQ:SOPH), a cloud-native software company in the healthcare space, has entered an agreement with Memorial Sloan Kettering Cancer Center (MSK) to offer clinicians and researchers new

SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

4 Jan 23

Press Releases

SOPHiA GENETICS SA (NASDAQ:SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023, at